Mechanism of miR-210 involved in epithelial–mesenchymal transition of pancreatic cancer cells under hypoxia

References

• Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin. 2010;60(5):277–300.
   PubMed Web of Science ®Google Scholar
• Hotz HG, Hotz B, Buhr HJ. Genes associated with epithelial-mesenchymal transition: possible therapeutic targets in ductal pancreatic adenocarcinoma? Anticancer Agents Med Chem. 2011;11(5):448–454.
   PubMed Web of Science ®Google Scholar
• Semenza GL. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene. 2010;29(5):625–634.
   PubMed Web of Science ®Google Scholar
• Cheng ZX, Sun B, Wang SJ, et al. Nuclear factor-κB-dependent epithelial to mesenchymal transition induced by HIF-1α activation in Pancreatic cancer cells under hypoxic conditions. PLoS One. 2011;6(8):e23752.
   PubMed Web of Science ®Google Scholar
• Elbashir SM, Martinez J, Patkaniowska A, et al. Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J. 2001;20(23):6877–6888.
   PubMed Web of Science ®Google Scholar
• Singh A, Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene. 2010;29(34):4741–4751.
   PubMed Web of Science ®Google Scholar
• Aiello NM, Brabletz T, Kang Y, et al. Upholding a role for EMT in pancreatic cancer metastasis. Nature. 2017;547(7661):E7–E8.
   PubMed Web of Science ®Google Scholar
• Krebs AM, Mitschke J, Losada M, et al. The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in Pancreatic cancer. Nat Cell Biol. 2017;19(5):518–529.
   PubMed Web of Science ®Google Scholar
• Arumugam T, Ramachandran V, Fournier KF, et al. Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer. Cancer Res. 2009;69(14):5820–5828.
   PubMed Web of Science ®Google Scholar
• Li Y, VandenBoom TG, Kong D, et al. Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Cancer Res. 2009;69(16):6704–6712.
   PubMed Web of Science ®Google Scholar
• Shah AN, Summy JM, Zhang J, et al. Development and characterization of gemcitabine-resistant Pancreatic tumor cells. Ann Surg Oncol. 2007;14(12):3629–3637.
   PubMed Web of Science ®Google Scholar
• Rhim AD, Mirek ET, Aiello NM, et al. EMT and dissemination precede Pancreatic tumor formation. Cell. 2012;148(1–2):349–361.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Wang J, Meng X, et al. A positive feedback loop promotes HIF-1α stability through miR-210-mediated suppression of RUNX3 in paraquat-induced EMT. J Cell Mol Med. 2017;21(12):3529–3539.
   PubMed Web of Science ®Google Scholar
• Harris AL. Hypoxia: a key regulatory factor in tumor growth. Nat Rev Cancer. 2002;2(1):38–47.
   PubMed Web of Science ®Google Scholar
• Chang Q, Jurisica I, Do T, et al. Hypoxia predicts aggressive growth and spontaneous metastasis formation from orthotopically grown primary xenografts of human pancreatic cancer. Cancer Res. 2011;71(8):3110–3120.
   PubMed Web of Science ®Google Scholar
• Jiang J, Tang YL, Liang XH. EMT: a new vision of hypoxia promoting cancer progression. Cancer Biol Ther. 2011;11(8):714–723.
   PubMed Web of Science ®Google Scholar
• Hotz B, Arndt M, Dullat S, et al. Epithelial to mesenchymal transition: expression of the regulators snail, slug, and twist in pancreatic cancer. Clin Cancer Res. 2007;13(16):4769–4776.
   PubMed Web of Science ®Google Scholar
• Cannito S, Novo E, Compagnone A, et al. Redox mechanisms switch on hypoxia-dependent epithelial- mesenchymal transition in cancer cells. Carcinogenesis. 2008;29(12):2267–2278.
   PubMed Web of Science ®Google Scholar
• Takikawa T, Masamune A, Hamada S, et al. miR-210 regulates the interaction between pancreatic cancer cells and stellate cells. Biochem Biophys Res Commun. 2013;437(3):433–439.
   PubMed Web of Science ®Google Scholar
• Devlin C, Greco S, Martelli F, et al. miR-210: more than a silent player in hypoxia. IUBMB Life. 2011;63(2):94–100.
   PubMed Web of Science ®Google Scholar
• Toyama T, Kondo N, Endo Y, et al. High expression of MicroRNA-210 is an independent factor indicating a poor prognosis in Japanese triple-negative breast cancer patients. Jpn J Clin Oncol. 2012;42(4):256–263. [Epub ahead of print] PMID：22323552.
   PubMed Web of Science ®Google Scholar
• Ying Q, Liang L, Guo W, et al. Hypoxia-inducible microRNA-210 augments the metastatic potential of tumor cells by targeting vacuole membrane protein 1 in hepatocellular carcinoma. Hepatology. 2011;54(6):2064–2075.
   PubMed Web of Science ®Google Scholar
• Szafranska AE, Davison TS, John J, et al. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene. 2007;26(30):4442–4452.
   PubMed Web of Science ®Google Scholar
• Bloomston M, Frankel WL, Petrocca F, et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal PANC-1reas and chronic PANC-1reatitis. JAMA. 2007;297(17):1901–1908.
   PubMed Web of Science ®Google Scholar
• Greither T, Grochola LF, Udelnow A, et al. Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival. Int J Cancer. 2010;126(1):73–80.
   PubMed Web of Science ®Google Scholar
• Tang T, Yang Z, Zhu Q, et al. Up-regulation of miR-210 induced by a hypoxic microenvironment promotes breast cancer stem cells metastasis, proliferation, and self-renewal by targeting E-cadherin. FASEB J. 2018;32(12):6965–6981.
   Web of Science ®Google Scholar
• Huang X, Ding L, Bennewith KL, et al. Hypoxia-inducible miR-210 regulates normoxic gene expression involved in tumor initiation. Mol Cell. 2009;35(6):856–867.
   PubMed Web of Science ®Google Scholar
• Halle M, Gabrielsen A, Paulsson-Berne G, et al. Sustained inflammation due to nuclear factor-kappa B activation in irradiated human arteries. J Am Coll Cardiol. 2010;55(12):1227–1236.
   PubMed Web of Science ®Google Scholar
• Yu SL, Lee DC, Sohn HA, et al. Homeobox A9 directly targeted by miR-196b regulates aggressiveness through nuclear Factor-kappa B activity in non-small cell lung cancer cells. Mol Carcinog. 2016;55(12):1915–1926.
   PubMed Web of Science ®Google Scholar
• Trivedi CM, Patel RC, Patel CV. Homeobox gene HOXA9 inhibits nuclear factor-kappa B dependent activation of endothelium. Atherosclerosis. 2007;195(2):e50–e60.
   PubMed Web of Science ®Google Scholar